Evidence map›Paper›PMID 27233767›Full record

ArticleAmerican journal of physiology. Heart and circulatory physiology2016

A post-MI power struggle: adaptations in cardiac power occur at the sarcomere level alongside MyBP-C and RLC phosphorylation.

Christopher N Toepfer, Markus B Sikkel, Valentina Caorsi, Anupama Vydyanath, Iratxe Torre, O'Neal Copeland, Alexander R Lyon, Steven B Marston, Pradeep K Luther, Kenneth T Macleod and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of physiology. Heart and circulatory physiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Regulatory Light Chains in Cardiac Development and Disease.International journal of molecular sciences · 2021
    Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 4 countries.

Christopher N ToepferMolecular Medicine Section, National Heart and Lung Institute, Imperial College London, London, United Kingdom; Laboratory of Molecular Physiology, National Heart and Lung Institute, National Institutes of Health, Bethesda, Maryland; christopher_toepfer@HMS.harvard.edu.
Markus B SikkelDepartment of Cardiac Medicine, National Heart and Lung Institute, Imperial College London, London, United Kingdom;
Valentina CaorsiMolecular Medicine Section, National Heart and Lung Institute, Imperial College London, London, United Kingdom; Laboratoire Physico-Chimie, UMR168, Institute Curie, Paris, France;
Anupama VydyanathMolecular Medicine Section, National Heart and Lung Institute, Imperial College London, London, United Kingdom;
Iratxe TorreMolecular Medicine Section, National Heart and Lung Institute, Imperial College London, London, United Kingdom;
O'Neal CopelandDepartment of Cardiac Medicine, National Heart and Lung Institute, Imperial College London, London, United Kingdom;
Alexander R LyonDepartment of Cardiac Medicine, National Heart and Lung Institute, Imperial College London, London, United Kingdom; Nationa Institute of Health Research Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, London, United Kingdom;
Steven B MarstonDepartment of Cardiac Medicine, National Heart and Lung Institute, Imperial College London, London, United Kingdom;
Pradeep K LutherMolecular Medicine Section, National Heart and Lung Institute, Imperial College London, London, United Kingdom;
Kenneth T MacleodDepartment of Cardiac Medicine, National Heart and Lung Institute, Imperial College London, London, United Kingdom;
Timothy G WestRoyal Veterinary College London, Structure & Motion Laboratory, North Mymms, United Kingdom; and.
Michael A FerencziMolecular Medicine Section, National Heart and Lung Institute, Imperial College London, London, United Kingdom; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.
Imperial College London · GBNanyang Technological University · SGRoyal Veterinary College · GB

Funding

Biotechnology and Biological Sciences Research Council BB/I019448/1British Heart Foundation PG/09/032/27241British Heart Foundation RG/11/20/29266British Heart Foundation RG/11/21/29335Wellcome TrustWellcome Trust 091460/Z/10/Z
6 · The paper itself

Abstract

Myocardial remodeling in response to chronic myocardial infarction (CMI) progresses through two phases, hypertrophic "compensation" and congestive "decompensation." Nothing is known about the ability of uninfarcted myocardium to produce force, velocity, and power during these clinical phases, even though adaptation in these regions likely drives progression of compensation. We hypothesized that enhanced cross-bridge-level contractility underlies mechanical compensation and is controlled in part by changes in the phosphorylation states of myosin regulatory proteins. We induced CMI in rats by left anterior descending coronary artery ligation. We then measured mechanical performance in permeabilized ventricular trabecula taken distant from the infarct zone and assayed myosin regulatory protein phosphorylation in each individual trabecula. During full activation, the compensated myocardium produced twice as much power and 31% greater isometric force compared with noninfarcted controls. Isometric force during submaximal activations was raised >2.4-fold, while power was 2-fold greater. Electron and confocal microscopy demonstrated that these mechanical changes were not a result of increased density of contractile protein and therefore not an effect of tissue hypertrophy. Hence, sarcomere-level contractile adaptations are key determinants of enhanced trabecular mechanics and of the overall cardiac compensatory response. Phosphorylation of myosin regulatory light chain (RLC) increased and remained elevated post-MI, while phosphorylation of myosin binding protein-C (MyBP-C) was initially depressed but then increased as the hearts became decompensated. These sensitivities to CMI are in accordance with phosphorylation-dependent regulatory roles for RLC and MyBP-C in crossbridge function and with compensatory adaptation in force and power that we observed in post-CMI trabeculae.

Indexed as

Adaptation, PhysiologicalAnimalsCarrier ProteinsCoronary VesselsLigationMaleMicroscopy, ConfocalMicroscopy, ElectronMyocardial ContractionMyocardial InfarctionMyocardiumMyocytes, CardiacMyosin Binding Protein CMyosin Light ChainsPhosphorylationRatsCarrier ProteinsMyosin Binding Protein CMyosin Light Chainscontractile apparatuscontractile functioninfarctionmyosin binding protein-Cregulatory light chain

Identifiers

PMID27233767
PMCPMC5005282
OpenAlexW2395941198

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.